Clinical Trial Update: Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of binimetinib and pembrolizumab for advanced non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Binimetinib (binimetinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non-small Cell Carcinoma | Phase 1 | Status: RECRUITING